choose a popular brand-name prescription drug, and explain how that drug may or may not have benefited from the intervention of the FDA during its development

Lisinopril. This has recently gotten recalled by the FDA in April 29, 2020

Explanation:

Lisinopril. This has recently gotten recalled by the FDA in April 2018. Lisinopril is used to treat kidney problems and heart failure post heart attack. The agency, which posted the recall of the to its Enforcement Report database, said that a customer discovered a 145mg fenofibrate tablet — used to lower high cholesterol and triglyceride levels — in a 500 count product bottle. I definitely think the company took a hard hit after the withdraw of their product. The drug, however, definitely benefited. It was put in the spotlight and also reduced to safer measures.

Explanation: